Gerard Riedy1, Justin S Senseney1, Wei Liu1, John Ollinger1, Elyssa Sham1, Pavel Krapiva1, Jigar B Patel1, Alice Smith1, Ping-Hong Yeh1, John Graner1, Dominic Nathan1, Jesus Caban1, Louis M French1, Jamie Harper1, Victoria Eskay1, John Morissette1, Terrence R Oakes1. 1. From the National Capital Neuroimaging Consortium (NCNC), Bethesda, Md (G.R., J.S.S., W.L., J.O., E.S., P.H.Y., J.G., D.N., J.C., J.H., V.E., J.M., T.R.O.); National Intrepid Center of Excellence (NICoE), 4860 S Palmer Rd, Bethesda, MD 20889 (G.R., J.S.S., W.L., J.O., E.S., P.H.Y., J.G., D.N., J.C., L.M.F., V.E., J.M., T.R.O.); Center for Neuroscience and Regenerative Medicine, Bethesda, Md (G.R., L.M.F.); Uniformed Services University of the Health Sciences, Bethesda, Md (G.R., A.S., L.M.F.); Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Md (P.H.Y.); Walter Reed National Military Medical Center (WRNMMC), Bethesda, Md (P.K., L.M.F.); and VA Maryland Health Care System (VAMHCS), Baltimore, Md (J.B.P.).
Abstract
PURPOSE: To describe the initial neuroradiology findings in a cohort of military service members with primarily chronic mild traumatic brain injury (TBI) from blast by using an integrated magnetic resonance (MR) imaging protocol. MATERIALS AND METHODS: This study was approved by the Walter Reed National Military Medical Center institutional review board and is compliant with HIPAA guidelines. All participants were military service members or dependents recruited between August 2009 and August 2014. There were 834 participants with a history of TBI and 42 participants in a control group without TBI (not explicitly age- and sex-matched). MR examinations were performed at 3 T primarily with three-dimensional volume imaging at smaller than 1 mm(3) voxels for the structural portion of the examination. The structural portion of this examination, including T1-weighted, T2-weighted, before and after contrast agent administrtion T2 fluid attenuation inversion recovery, and susceptibility-weighted images, was evaluated by neuroradiologists by using a modified version of the neuroradiology TBI common data elements (CDEs). Incident odds ratios (ORs) between the TBI participants and a comparison group without TBI were calculated. RESULTS: The 834 participants were diagnosed with predominantly chronic (mean, 1381 days; median, 888 days after injury) and mild (92% [768 of 834]) TBI. Of these participants, 84.2% (688 of 817) reported one or more blast-related incident and 63.0% (515 of 817) reported loss of consciousness at the time of injury. The presence of white matter T2-weighted hyperintense areas was the most common pathologic finding, observed in 51.8% (432 of 834; OR, 1.75) of TBI participants. Cerebral microhemorrhages were observed in a small percentage of participants (7.2% [60 of 834]; OR, 6.64) and showed increased incidence with TBI severity (P < .001, moderate and severe vs mild). T2-weighted hyperintense areas and microhemorrhages did not collocate by visual inspection. Pituitary abnormalities were identified in a large proportion (29.0% [242 of 834]; OR, 16.8) of TBI participants. CONCLUSION: Blast-related injury and loss of consciousness is common in military TBI. Structural MR imaging demonstrates a high incidence of white matter T2-weighted hyperintense areas and pituitary abnormalities, with a low incidence of microhemorrhage in the chronic phase.
PURPOSE: To describe the initial neuroradiology findings in a cohort of military service members with primarily chronic mild traumatic brain injury (TBI) from blast by using an integrated magnetic resonance (MR) imaging protocol. MATERIALS AND METHODS: This study was approved by the Walter Reed National Military Medical Center institutional review board and is compliant with HIPAA guidelines. All participants were military service members or dependents recruited between August 2009 and August 2014. There were 834 participants with a history of TBI and 42 participants in a control group without TBI (not explicitly age- and sex-matched). MR examinations were performed at 3 T primarily with three-dimensional volume imaging at smaller than 1 mm(3) voxels for the structural portion of the examination. The structural portion of this examination, including T1-weighted, T2-weighted, before and after contrast agent administrtion T2 fluid attenuation inversion recovery, and susceptibility-weighted images, was evaluated by neuroradiologists by using a modified version of the neuroradiology TBI common data elements (CDEs). Incident odds ratios (ORs) between the TBI participants and a comparison group without TBI were calculated. RESULTS: The 834 participants were diagnosed with predominantly chronic (mean, 1381 days; median, 888 days after injury) and mild (92% [768 of 834]) TBI. Of these participants, 84.2% (688 of 817) reported one or more blast-related incident and 63.0% (515 of 817) reported loss of consciousness at the time of injury. The presence of white matter T2-weighted hyperintense areas was the most common pathologic finding, observed in 51.8% (432 of 834; OR, 1.75) of TBI participants. Cerebral microhemorrhages were observed in a small percentage of participants (7.2% [60 of 834]; OR, 6.64) and showed increased incidence with TBI severity (P < .001, moderate and severe vs mild). T2-weighted hyperintense areas and microhemorrhages did not collocate by visual inspection. Pituitary abnormalities were identified in a large proportion (29.0% [242 of 834]; OR, 16.8) of TBI participants. CONCLUSION: Blast-related injury and loss of consciousness is common in military TBI. Structural MR imaging demonstrates a high incidence of white matter T2-weighted hyperintense areas and pituitary abnormalities, with a low incidence of microhemorrhage in the chronic phase.
Authors: David F Tate; Benjamin S C Wade; Carmen S Velez; Ann Marie Drennon; Jacob Bolzenius; Boris A Gutman; Paul M Thompson; Jeffrey D Lewis; Elisabeth A Wilde; Erin D Bigler; Martha E Shenton; John L Ritter; Gerald E York Journal: J Neurol Date: 2016-07-19 Impact factor: 4.849
Authors: Andrew P Klein; Julie E Tetzlaff; Joshua M Bonis; Lindsay D Nelson; Andrew R Mayer; Daniel L Huber; Jaroslaw Harezlak; Vincent P Mathews; John L Ulmer; Grant P Sinson; Andrew S Nencka; Kevin M Koch; Yu-Chien Wu; Andrew J Saykin; John P DiFiori; Christopher C Giza; Joshua Goldman; Kevin M Guskiewicz; Jason P Mihalik; Stefan M Duma; Steven Rowson; Alison Brooks; Steven P Broglio; Thomas McAllister; Michael A McCrea; Timothy B Meier Journal: J Neurotrauma Date: 2019-02-25 Impact factor: 5.269
Authors: Philip A Cook; Thomas M Johnson; Suzanne G Martin; Philip R Gehrman; Seema Bhatnagar; James C Gee Journal: J Neurotrauma Date: 2018-03-01 Impact factor: 5.269
Authors: Allison D Griffin; L Christine Turtzo; Gunjan Y Parikh; Alexander Tolpygo; Zachary Lodato; Anita D Moses; Govind Nair; Daniel P Perl; Nancy A Edwards; Bernard J Dardzinski; Regina C Armstrong; Abhik Ray-Chaudhury; Partha P Mitra; Lawrence L Latour Journal: Brain Date: 2019-11-01 Impact factor: 13.501
Authors: Kacie L Wright; Ramona O Hopkins; Frank E Robertson; Erin D Bigler; H Gerry Taylor; Kenneth H Rubin; Kathryn Vannatta; Terry Stancin; Keith Owen Yeates Journal: J Neurotrauma Date: 2020-05-15 Impact factor: 5.269